“Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients With Metastatic Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S79. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/475.